BATH & BODY WORKS, INC.
Income Statement
| Line Item | Aug 2026 | May 2026 | Jan 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.51B | $1.38B | $2.72B | $1.59B | $1.55B | $1.42B | $2.79B | $1.61B |
| Cost of Revenue | $822.0M | $791.0M | $1.48B | $936.0M | $909.0M | $778.0M | $1.49B | $910.0M |
| Gross Profit | $692.0M | $587.0M | $1.25B | $658.0M | $640.0M | $646.0M | $1.30B | $700.0M |
| Gross Margin | 45.7% | 42.6% | 45.7% | 41.3% | 41.3% | 45.4% | 46.7% | 43.5% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $476.0M | $356.0M | $646.0M | $497.0M | $483.0M | $437.0M | $624.0M | $482.0M |
| Operating Income | $216.0M | $231.0M | $599.0M | $161.0M | $157.0M | $209.0M | $678.0M | $218.0M |
| Operating Margin | 14.3% | 16.8% | 22.0% | 10.1% | 10.1% | 14.7% | 24.3% | 13.5% |
| Interest Expense | $63.0M | $69.0M | $69.0M | $68.0M | $68.0M | $71.0M | $76.0M | $77.0M |
| Pretax Income | $164.0M | $166.0M | $538.0M | $103.0M | $95.0M | $146.0M | $612.0M | $145.0M |
| Income Tax Expense | $46.0M | $-17.0M | $135.0M | $26.0M | $31.0M | $41.0M | $159.0M | $39.0M |
| Net Income | $118.0M | $183.0M | $403.0M | $77.0M | $64.0M | $105.0M | $453.0M | $106.0M |
| Net Margin | 7.8% | 13.3% | 14.8% | 4.8% | 4.1% | 7.4% | 16.3% | 6.6% |
| EPS (Basic) | $0.59 | $0.91 | $1.94 | $0.38 | $0.31 | $0.49 | $2.06 | $0.49 |
| EPS (Diluted) | $0.58 | $0.90 | $1.95 | $0.37 | $0.30 | $0.49 | $2.06 | $0.49 |
| Shares Outstanding (Basic) | 201.0M | 201.0M | 208.0M | 205.0M | 210.0M | 214.0M | 220.0M | 218.0M |
| Shares Outstanding (Diluted) | 202.0M | 202.0M | 209.0M | 206.0M | 211.0M | 215.0M | 221.0M | 219.0M |
| Dividends Per Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 |